Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-28 Purchase | 2026-09-30 5:29 pm | ADARx Pharmaceuticals Inc. | ADRX | Chimovits Erez Director | 61,516 | $17 | $1,045,772 | 9,292,025 (Indirect) | View |
| 2026-09-28 Purchase | 2026-09-30 5:25 pm | ADARx Pharmaceuticals Inc. | ADRX | GORDON CARL L Director 10% Owner | 950,000 | $17 | $16,150,000 | 588,235 (Indirect) | View |
| 2026-09-28 Purchase | 2026-09-30 5:23 pm | ADARx Pharmaceuticals Inc. | ADRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Genesis GP LLC Director 10% Owner | 950,000 | $17 | $16,150,000 | 588,235 (Indirect) | View |
| 2026-09-28 Purchase | 2026-09-29 9:45 pm | ADARx Pharmaceuticals Inc. | ADRX | SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 1,600,000 | $17 | $27,200,000 | 592,593 (Indirect) | View |
| 2026-09-28 Purchase | 2026-09-29 9:43 pm | ADARx Pharmaceuticals Inc. | ADRX | George Simeon Director 10% Owner | 1,600,000 | $17 | $27,200,000 | 592,593 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-28 Conversion | 2026-09-30 5:29 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | Chimovits Erez Director | 9,230,509 | $0 | 9,292,025 (Indirect) | View |
| 2026-09-28 Conversion | 2026-09-30 5:25 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | GORDON CARL L Director 10% Owner | 23,255,789 | $0 | 588,235 (Indirect) | View |
| 2026-09-28 Conversion | 2026-09-30 5:23 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Genesis GP LLC Director 10% Owner | 23,255,789 | $0 | 588,235 (Indirect) | View |
| 2026-09-28 Conversion | 2026-09-29 9:45 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 18,104,730 | $0 | 592,593 (Indirect) | View |
| 2026-09-28 Conversion | 2026-09-29 9:43 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | George Simeon Director 10% Owner | 18,104,730 | $0 | 592,593 (Indirect) | View |
| 2026-09-28 Conversion | 2026-09-29 9:38 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | LAV Biosciences Fund V L.P. LAV Fund VI Opportunities L.P. LAV Fund VI L.P. 10% Owner | 25,445,706 | $0 | 11,550,917 (Direct) | View |
| 2026-09-24 Option Award | 2026-09-28 4:30 pm | N/A 2036-09-23 | ADARx Pharmaceuticals Inc. | ADRX | Zhu Rui (NMN) Chief Technology Officer | 512,076 | $0 | 512,076 (Direct) | View |
| 2026-09-24 Option Award | 2026-09-28 4:30 pm | N/A 2036-09-23 | ADARx Pharmaceuticals Inc. | ADRX | MacLeod Alan Robert Chief Scientific Officer | 170,692 | $0 | 170,692 (Direct) | View |
| 2026-09-24 Option Award | 2026-09-28 4:30 pm | N/A 2036-09-23 | ADARx Pharmaceuticals Inc. | ADRX | Fisk Ryan CFO and CBO | 170,692 | $0 | 170,692 (Direct) | View |
| 2026-09-24 Option Award | 2026-09-28 4:30 pm | N/A 2036-09-23 | ADARx Pharmaceuticals Inc. | ADRX | Li Zhen President and CEO 10% Owner | 1,024,152 | $0 | 1,024,152 (Direct) | View |
| 2026-09-24 Option Award | 2026-09-28 4:30 pm | N/A 2036-09-23 | ADARx Pharmaceuticals Inc. | ADRX | Ackles Robert William Chief People Officer | 85,346 | $0 | 85,346 (Direct) | View |
Ownership | 2026-09-24 7:06 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | George Simeon Director 10% Owner | 0 | $0 | 8,336,661 (Indirect) | View |
Ownership | 2026-09-24 7:05 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | SR ONE CAPITAL MANAGEMENT LLC 10% Owner | 0 | $0 | 8,336,661 (Indirect) | View |
Ownership | 2026-09-24 6:57 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd Director 10% Owner | 0 | $0 | 23,255,789 (Indirect) | View |
Ownership | 2026-09-24 6:43 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | LAV Biosciences Fund V L.P. LAV Fund VI Opportunities L.P. LAV Fund VI L.P. 10% Owner | 0 | $0 | 11,858,655 (Direct) | View |
Ownership | 2026-09-24 6:41 pm | N/A 2036-07-19 | ADARx Pharmaceuticals Inc. | ADRX | Huang Ying Director | 0 | $0 | 267,792 (Direct) | View |
Ownership | 2026-09-24 6:40 pm | N/A 2035-11-21 | ADARx Pharmaceuticals Inc. | ADRX | TAGLIAFERRI MARY Director | 0 | $0 | 357,056 (Direct) | View |
Ownership | 2026-09-24 6:39 pm | N/A 2036-08-16 | ADARx Pharmaceuticals Inc. | ADRX | Ackles Robert William Chief People Officer | 0 | $0 | 335,633 (Direct) | View |
Ownership | 2026-09-24 6:38 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | Chimovits Erez Director | 0 | $0 | 9,230,509 (Indirect) | View |
Ownership | 2026-09-24 6:38 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | Zhu Rui (NMN) Chief Technology Officer | 0 | $0 | 3,789,802 (Direct) | View |
Ownership | 2026-09-24 6:37 pm | N/A 2033-02-25 | ADARx Pharmaceuticals Inc. | ADRX | MacLeod Alan Robert Chief Scientific Officer | 0 | $0 | 667,023 (Direct) | View |
Ownership | 2026-09-24 6:36 pm | N/A 2036-03-23 | ADARx Pharmaceuticals Inc. | ADRX | Fisk Ryan CFO and CBO | 0 | $0 | 865,864 (Direct) | View |
Ownership | 2026-09-24 6:35 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | GORDON CARL L Director 10% Owner | 0 | $0 | 23,255,789 (Indirect) | View |
Ownership | 2026-09-24 6:35 pm | N/A N/A | ADARx Pharmaceuticals Inc. | ADRX | Li Zhen President and CEO 10% Owner | 0 | $0 | 11,821,985 (Indirect) | View |